Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +55.6% | +284.1% | 3 / 3 | -13.2% | +5.25 pp | +1.68 pp | +9.9% | 2.65 | 4.87 | 920 | −13,2% | 34,9 | +55,6% | 4.87 | 8.18 | −40,5% |
| Pts | 8 | 12 | 12 | 0 | 12 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 7.000 (close price on 2026-10-19)EPS (TTM): 1.437
Financial charts
1.Revenue & growth
VND bn920Q2/26
1.Revenue & growth
VND bn920Q2/26
2.Profit & growth
VND bn34,9Q2/26
3.Profit mix (Penman)
VND bn117Q2/26
4.Margins & cost structure
%9.2%Q2/26
5.Returns & cash cycle
% · days7.2%Q2/26
6.Earnings quality & cash
VND bn-444Q2/26
7.Asset structure
VND bn4.654Q2/26
8.Funding & debt health
VND bn · times4.654Q2/26
9.Revenue backlog
VND bn889Q2/26
10.Valuation
times · %4,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %582Q2/26
Adjusted EPS growth, latest quarter
55.6%
Average adjusted EPS growth, 3 quarters
284%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26